Search Orphan Drug Designations and Approvals
-
Generic Name: | octreotide acetate (intranasal) |
---|---|
Date Designated: | 01/23/2018 |
Orphan Designation: | Treatment of acromegaly |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 08/08/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Dauntless Pharmaceuticals, Inc. 12390 El Camino Real Suite 170 San Diego, California 92130 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-